BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18161655)

  • 1. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection.
    Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM
    Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
    Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
    J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
    Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
    Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients.
    Braakhuis BJ; Rietbergen MM; Buijze M; Snijders PJ; Bloemena E; Brakenhoff RH; Leemans CR
    Oral Dis; 2014 Sep; 20(6):602-8. PubMed ID: 24112103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.
    Lee LA; Huang CG; Liao CT; Lee LY; Hsueh C; Chen TC; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Yang SL; Tsao KC; Chang YL; Yen TC
    PLoS One; 2012; 7(7):e40767. PubMed ID: 22808258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
    Huang Q; Li F; Ji M; Lin L; Hu C
    BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India.
    Nagpal JK; Patnaik S; Das BR
    Int J Cancer; 2002 Feb; 97(5):649-53. PubMed ID: 11807792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
    Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
    Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
    Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
    Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia.
    Saini R; Tang TH; Zain RB; Cheong SC; Musa KI; Saini D; Ismail AR; Abraham MT; Mustafa WM; Santhanam J
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):311-20. PubMed ID: 20419384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.
    Chuerduangphui J; Pientong C; Patarapadungkit N; Chotiyano A; Vatanasapt P; Kongyingyoes B; Promthet S; Swangphon P; Bumrungthai S; Pimson C; Ekalaksananan T
    Med Oncol; 2017 Sep; 34(9):148. PubMed ID: 28741068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
    Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
    PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.
    Malisic E; Jankovic R; Jakovljevic K; Radulovic S
    J BUON; 2011; 16(4):701-7. PubMed ID: 22331725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
    Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R
    Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation.
    Lohavanichbutr P; Méndez E; Holsinger FC; Rue TC; Zhang Y; Houck J; Upton MP; Futran N; Schwartz SM; Wang P; Chen C
    Clin Cancer Res; 2013 Mar; 19(5):1197-203. PubMed ID: 23319825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
    Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.